Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00861
Species: Homo sapiens
Position : chr11:75928700-75928930
Year: 2019
Title: Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: small cell lung carcinoma
PMID:  31231131
MONDO: MONDO:0005020
Tissue: Lung
Tissue Ontology ID: UBERON:0002048
Cell Source: SCLC cell line H889
CVCL ID: CVCL_1599
Cell Type: small cell lung carcinoma cell
Cell Ontology ID: CL:0000066
Experiment Type: TF binding assay, Functional perturbation assay
High Throughput Method: ChIP-seq, RNA-seq
Low Throughput Method: ChIP-RT-qPCR, RT-RT-qPCR, Western blot
About Target Gene
Target gene :
About TF
TF name : ASCL1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
ASCL1 Notch-mediated HES/HEY network pid 48
ASCL1 Notch netpath 76
ASCL1 Hs_Dopaminergic_Neurogenesis_WP2855_87239 wikipathways 19
ASCL1 Hs_Neural_Crest_Differentiation_WP2064_79263 wikipathways 40
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_01246 chr11:75928700-75928930 Lung small cell lung carcinoma cell small cell lung carcinoma
Expression of Target Genes for the Enhancer